CN Stock MarketDetailed Quotes

Changchun Bcht Biotechnology (688276)

Watchlist
  • 20.14
  • -0.06-0.30%
Post Market Jan 16 15:00 CST
8.33BMarket Cap-48.88P/E (TTM)

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Changchun Bcht Biotechnology (688276) Revenue Breakdown Overview

By Product

Currency:CNY
2025/H1
Stock NameRevenueRatio
Sell goods284.9M100.00%

By Industry

Currency:CNY
2024/FY
Stock NameRevenueRatio
Biological medicine1.23B100.00%
Total special adjustments-2--

By Country/Region

Currency:CNY
2025/H1
Stock NameRevenueRatio
East China129.59M45.49%
South China55.34M19.43%
Southwest43.13M15.14%
Northeast China21.4M7.51%
Northwest20.32M7.13%
Central China14.79M5.19%
Abroad9.71M3.41%
North China-9.38M-3.29%
View all

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
HK Tech and Internet Stocks
No. Symbol 5D % Chg
Sample Name
Sample Code
 +17.33%
Sample Name
Sample Code
 +15.85%
Sample Name
Sample Code
 +13.11%
4
BIDU-SW
09888
+5.31%
5
JD HEALTH
06618
+5.25%
View More
Nancy Pelosi Portfolio
No. Symbol % Chg
Sample Name
Sample Code
 +6.63%
Sample Name
Sample Code
 +3.27%
Sample Name
Sample Code
 +2.15%
4
NVIDIA
NVDA
+2.13%
5
Broadcom
AVGO
+0.92%
Will the 'tariff stick' strike again? Will the market remain 'reactive'?
China and the United States have successively adjusted multiple tariff and non-tariff measures, beginning to implement the consensus outcome Show More
[Opportunity Express] The US-China rivalry escalates! The rare earth industry becomes a "game-changer." How should investors respond?
"Leaving the Group - Raising Taxes - Tweeting: The 'Money Making Strategy' of the Most Wild Gemini in Contemporary Times"

- No more -